Instil Bio(TIL)
$6.31-0.04 (-0.63%)
TIL
Instil Bio financials statements
$6.31
At close:-0.04 (-0.63%)
Want to see TIL full AI Analyst Report?
Instil Bio (TIL) Ratios
369 Followers
Instil Bio Ratios
TIL's free cash flow for Q2 2026 was $-4.64M. For the 2026 fiscal year, TIL's free cash flow was increased by $0.00 and operating cash flow was $-4.64M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 39.53 | 15.76 | 15.22 | 8.22 | 11.22 |
| Quick Ratio | 39.53 | 15.76 | 15.22 | 8.22 | 11.22 |
| Cash Ratio | 1.37 | 1.12 | 0.87 | 1.33 | 0.91 |
| Solvency Ratio | -0.79 | -0.75 | -1.52 | -1.83 | -2.81 |
| Operating Cash Flow Ratio | -7.56 | -7.05 | -7.77 | -5.49 | -2.95 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 101.77M | $ 30.34M | $ 60.96M | $ 150.85M | $ 409.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.42 | 0.33 | 0.26 | 0.17 | 0.00 |
| Debt-to-Equity Ratio | 0.75 | 0.51 | 0.38 | 0.22 | 0.00 |
| Debt-to-Capital Ratio | 0.43 | 0.34 | 0.28 | 0.18 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.43 | 0.33 | 0.27 | 0.17 | 0.00 |
| Financial Leverage Ratio | 1.79 | 1.56 | 1.44 | 1.33 | 1.10 |
| Debt Service Coverage Ratio | -11.15 | -6.95 | -28.24 | -114.34 | 0.00 |
| Interest Coverage Ratio | -9.08 | -8.18 | -30.56 | -109.49 | 0.00 |
| Debt to Market Cap | 1.16 | 0.68 | 1.64 | 0.89 | 0.00 |
| Interest Debt Per Share | 13.65 | 14.73 | 14.03 | 12.63 | 0.00 |
| Net Debt to EBITDA | -1.21 | -1.25 | -0.52 | -0.17 | 0.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 99.08% | 100.02% |
| EBT Per EBIT | 134.90% | 100.81% | 98.06% | 109.25% | 100.77% |
| Return on Assets (ROA) | -35.07% | -28.13% | -47.93% | -46.29% | -25.70% |
| Return on Equity (ROE) | -62.68% | -43.75% | -69.12% | -61.38% | -28.24% |
| Return on Capital Employed (ROCE) | -26.63% | -28.76% | -50.52% | -45.88% | -27.36% |
| Return on Invested Capital (ROIC) | -26.58% | -28.58% | -50.24% | -45.22% | -27.36% |
| Return on Tangible Assets | -35.07% | -28.13% | -47.93% | -46.29% | -26.39% |
| Earnings Yield | -97.30% | -59.65% | -314.95% | -273.52% | -8.65% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.69 | 0.00 | 0.00 | 2.54 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -532.46 | 0.00 | 0.00 | -143.82 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 532.46 | 0.00 | 0.00 | 143.82 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5.49 | -8.56 | -12.61 | -27.82 | -23.05 |
| Free Cash Flow Per Share | -5.49 | -10.09 | -15.79 | -40.88 | -33.96 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -5.57 | -3.97 | -2.13 | -2.11 |
| Capital Expenditure Coverage Ratio | 0.00 | -5.57 | -3.97 | -2.13 | -2.11 |
| Operating Cash Flow Coverage Ratio | -0.43 | -0.64 | -0.95 | -2.25 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -49.92% | -52.86% | -207.21% | -324.48% | -9.92% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.03 | -1.68 | -0.32 | -0.37 | -11.57 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.64 | 0.73 | 0.22 | 0.22 | 3.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.00 | -1.89 | -0.48 | -0.31 | -10.08 |
| Price-to-Operating Cash Flow Ratio | -2.00 | -2.23 | -0.60 | -0.45 | -14.85 |
| Price-to-Earnings Growth (PEG) Ratio | 0.17 | 0.03 | 0.01 | -0.02 | -0.03 |
| Enterprise Value Multiple | -2.34 | -3.24 | -0.86 | -0.54 | -11.64 |
| Enterprise Value | 151.89M | 202.36M | 126.42M | 117.78M | 1.78B |
| EV to EBITDA | -2.34 | -3.24 | -0.86 | -0.54 | -11.64 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -4.15 | -3.08 | -1.23 | -0.44 | -9.87 |
| EV to Operating Cash Flow | -4.15 | -3.63 | -1.54 | -0.65 | -14.54 |
| Tangible Book Value Per Share | 17.08 | 26.03 | 34.72 | 56.15 | 101.78 |
| Shareholders’ Equity Per Share | 17.08 | 26.03 | 34.72 | 56.15 | 104.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.01 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -10.70 | -11.39 | -24.00 | -34.46 | -29.59 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 |
| Interest Burden | 1.09 | 1.12 | 1.03 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.51 | 0.75 | 0.53 | 0.81 | 0.78 |
Currency in USD
